NOD2 and steatosis: NOD2 expressed in non-hematopoietic cells, rather than in hematopoietic cells, protects against insulin resistance and metabolic inflammation, because hepatocyte-specific NOD2 deletion resulted in the development of severe steatosis and hepatic fibrosis (47).